Chen Cheng1 et al. Acta Pharmacol Sin 2013; 34: 1337–1348;

Slides:



Advertisements
Similar presentations
P247. Figure 9-1 p248 Figure 9-2 p251 p251 Figure 9-3 p253.
Advertisements

Location, Structure, and Dynamics of the Synthetic Cannabinoid Ligand CP-55,940 in Lipid Bilayers Tomohiro Kimura, Kejun Cheng, Kenner C. Rice, Klaus Gawrisch.
Definition of measurements and patients Michael J. Murphy, et al. Br J Clin Pharmacol 2008;65:
Volume 9, Issue 8, Pages (August 2017)
Fig. 1. Intravenous glucose infusion rates during an isoglycemic intravenous glucose infusion (IIGI) study in subjects with (A) normal glucose tolerance.
Oral Levosimendan Increases Cerebral Blood Flow Velocities in Patients with a History of Stroke or Transient Ischemic Attack: A Pilot Safety Study  Matti.
Date of download: 11/11/2017 Copyright © ASME. All rights reserved.
Comparing paediatric intravenous phenytoin doses using physiologically based pharmacokinetic (PBPK) modelling software  Hannah Batchelor, Richard Appleton,
The Constraints, Construction, and Verification of a Strain-Specific Physiologically Based Pharmacokinetic Rat Model  Helen Musther, Matthew D. Harwood,
Figure 4 Example of PK/PD simulation to optimize a vinorelbine treatment regimen Figure 4 | Example of PK/PD simulation to optimize a vinorelbine treatment.
Grepafloxacin: microbiological properties
Nat. Rev. Cardiol. doi: /nrcardio
administration (single dose, 5 mg) in six healthy male volunteers.
Martin C. Michel, Cees Korstanje, Walter Krauwinkel, Mirjam Kuipers 
Pharmacokinetics of Ganciclovir after Oral Valganciclovir versus Intravenous Ganciclovir in Allogeneic Stem Cell Transplant Patients with Graft-versus-Host.
Comparing paediatric intravenous phenytoin doses using physiologically based pharmacokinetic (PBPK) modelling software  Hannah Batchelor, Richard Appleton,
Wei Shi et al. Acta Pharmacol Sin 2013; 34: 342–351;
different predicted values (D)
low-sedentary control group (LHS)
Dong Feng1 et al. Acta Pharmacol Sin 2015; 36: 1462–1472;
Volume 62, Issue 2, Pages (August 2002)
Rats (open cycle), HFD rats (open triangle) and DM rats (solid cycle)
Impact of Tamsulosin OCAS on Energy of Patients with LUTS/BPH
James F. List, Jean M. Whaley  Kidney International 
Geometric mean concentration-time profiles of (A) racemic BUP, R-BUP, and S-BUP; (B) racemic OHBUP, RR-OHBUP, and SS-OHBUP; (C) racemic ERY, SR-ERYHBUP,
Plasma concentration–time profile, relative bioavailability and pharmacokinetic (PK) parameters of 4 mg TAK-228 in the single-agent QD PK run-in period,
Figure 2 Mean serum concentrations of BIIB033 vs time(A) Single ascending dose study and (B) multiple ascending dose study. Mean serum concentrations of.
Classification of statins/dosages according to the attainable
Observed (symbols) and model predicted (lines) dopamine time courses in rats following D-amphetamine administration. Observed (symbols) and model predicted.
Voriconazole tissue and fluid concentrations in humans as multiples of the maximal or simultaneously measured concentration in plasma (μg/ml) after systemic.
Concentrations of abemaciclib in plasma and cerebrospinal fluid (CSF).
Volume 66, Issue 1, Pages (July 2004)
Pharmacokinetics of Multiple-Dose Levofloxacin in Hemodialysis Patients  Shuichi Tsuruoka, MD, PhD, Noritsugu Yokota, MD, PhD, Tokie Hayasaka, RN, Tetsuo.
Dan-dan Tian1, 2 et al. Acta Pharmacol Sin 2015; 36: 627–643;
Recent experience with high-dose intravenous iron administration
Proteins in Plant Brassinosteroid Signaling
Figure Diagrammatic levodopa pharmacokinetics after single doses of immediate release (IR) carbidopa/levodopa (CD/LD) and 3 strengths of extended release.
Pharmacodynamic and pharmacokinetic considerations in antimicrobial selection: focus on telithromycin  G. Drusano  Clinical Microbiology and Infection 
Nanoemulsions as Versatile Formulations for Paclitaxel Delivery: Peroral and Dermal Delivery Studies in Rats  Sateesh Khandavilli, Ramesh Panchagnula 
Blood alcohol concentration and psychomotor effects
Montelukast adult (10-mg film-coated tablet) and pediatric (5-mg chewable tablet) dose selections  Barbara Knorr, MDa, Sherry Holland, PhDb, J.Douglas.
Cameron Mcleod, Alan Cox, Neil Bramall  Kidney International 
Fig. 4. Clearance of 12-mer-1 from a nonhuman primate model.
Chronic effect of 28-day oral administration of vehicle (n = 6–10/group) or aprocitentan 1, 10, and 100 mg/kg per day (n = 6–9/group) on mean arterial.
Effect of 11-day oral administration of vehicle (n = 4) or 6-day oral administration of enalapril 10 mg/kg per day (n = 19), followed by 5-day oral administration.
Leo F. Buckley et al. JCHF 2016;4:1-8
Dan-dan Tian1, 2 et al. Acta Pharmacol Sin 2015; 36: 627–643;
Lanthanum pharmacokinetics: Are rat data misleading?
Obesity affected the metabolic response to stroke.
Maximum mean (SE) per cent change in serum urate from baseline (Emax) following once-daily oral administration of varying verinurad doses in combination.
Mean (SD) AMG 557 serum concentration–time profiles following single-ascending dose (SAD) (A) and multiple-ascending dose (MAD) (B) administration AMG.
(A) Plasma renin activity in Wistar rats, SHRs, and DOCA-salt rats, n = 8 to 9/group; data are presented as mean ± S.E.M. Dose-response relationship on.
Typical response-time courses obtained after different doses and routes of administration (3 and 10 µg i.v., and 10, 50, and 100 µg s.c.). Typical response-time.
Effect of the acute administration of benzylamine plus vanadate on oral glucose tolerance test in STZ-induced diabetic rats. Effect of the acute administration.
A: The change of plasma glucose in opioid μ-receptor knockout diabetic mice and wild-type controls receiving an oral intake of metformin (100 mg/kg). A:
Mean ± SEM concentration of insulin in plasma and CSF and glucose in plasma 30 min after the intraperitoneal administration of DET or NPH insulin at different.
Plasma growth hormone concentrations during a 65-min infusion of acyl ghrelin at 0.3, 0.9, or 1.5 nmol/kg/h, or saline. Plasma growth hormone concentrations.
Mean plasma concentrations of ampicillin/sulbactam in plasma of critically ill patients with AKI undergoing extended dialysis (duration depicted by box.
Intracerebroventricular (ICV) insulin infusion increases TG secretion.
A loading dose decreases the time to achieve the target concentration.
Mean (SE) maximum urinary uric acid excretion rate (mg/hour) following verinurad doses in combination with febuxostat 40 or 80 mg vs febuxostat 40 or 80 mg.
Enrollment, outcomes, and pharmacokinetics.
IL-6 production with increasing doses of endotoxin.
Venous blood concentrations in nanograms of nicotine per millilitre (ng/ml) of plasma as a function of time for various nicotine delivery systems; all.
(Top) Observed (symbols) and model-predicted (lines) response-time data for latanoprost at the 0.1, 1.0, and 10 µg dose levels in the cat eye. (Top) Observed.
CAT displays very high in vivo stability as exemplified by a rat PK study. CAT displays very high in vivo stability as exemplified by a rat.
Gentamicin plasma and peritoneal dialysate concentrations in peritoneal dialysis patients with peritonitis. Gentamicin plasma and peritoneal dialysate.
Dose adjustments in patients with CKD are based on the change in the concentration-time profile for the drug of interest. Dose adjustments in patients.
Plasma concentration-time profile after oral administration of a single dose. Plasma concentration-time profile after oral administration of a single dose.
Pharmacodynamic and pharmacokinetic evaluation of EXE-RM-LNC in a high-fat diet (HFD)-induced obese/diabetic mouse model following acute treatment. Pharmacodynamic.
Presentation transcript:

Chen Cheng1 et al. Acta Pharmacol Sin 2013; 34: 1337–1348; Figure 5 Rat plasma concentration-time profiles of borneol, isoborneol, and their metabolite camphor after an oral dose of Bingpian (20 mg borneol/kg), synthetic Bingpian (20 mg borneol+isoborneol/kg), or Fufang-Danshen tablets (containing synthetic Bingpian; 20 mg borneol+isoborneol/kg) or an intravenous dose of Bingpian (5 mg borneol/kg) or synthetic Bingpian (5 mg borneol+isoborneol/kg) Figure legends Chen Cheng1 et al. Acta Pharmacol Sin 2013; 34: 1337–1348; doi: 10.1038/aps.2013.86 Published by © 2013 CPS and SIMM